Cancer treatment reviews

Keyphrases

Publications

volume 130, 2024

Ursula Ganz-Blaettler, Sarah Jayne Liptrott, Angela Tolotti, Marco Cefalì, Christine Aeschlimann, Simona Berardi Vilei, Ilaria Colombo, Evi Hatziandreou, Thanos Kosmidis, Helena Linardou, Rosemarie Pfau, Stavroula Sgourou, Cristiana Sessa
The active involvement of patients in oncology research. Cancer treatment reviews 130 (2024)
Manqi Hua, Fei Xiong, Shan Chong, Zhuo Zhang, Qianxin Liu, Jingyi Hou, Zhiqi Zhang, Zhichun Gu, Xiangli Cui, Yimin Cui, Ling Xu, Qian Xiang
Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation. Cancer treatment reviews 130 (2024)
A Boulouta, A Kyriazoglou, I Kotsantis, P Economopoulou, M Anastasiou, A Pantazopoulos, M Kyrkasiadou, M Moutafi, N Gavrielatou, E Zazas, C Caglar, I Nixon, M Tolia, G Kavourakis, A Psyrri
Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review. Cancer treatment reviews 130 (2024)
Abdul-Hamid Bazarbachi, Hervé Avet-Loiseau, Jean-Luc Harousseau, Ali Bazarbachi, Mohamad Mohty
Precision medicine for multiple myeloma: The case for translocation (11;14). Cancer treatment reviews 130 (2024)
Annalice Gandini, Julien Taieb, Hélène Blons, Jeanne Netter, Pierre Laurent-Puig, Claire Gallois
Early-Onset colorectal Cancer: From the laboratory to the clinic. Cancer treatment reviews 130 (2024)
Roberto Moretto, Guglielmo Vetere, Martina Carullo, Paolo Ciracì, Gianluca Masi, Chiara Cremolini
Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trials. Cancer treatment reviews 130 (2024)
Alberto Zambelli, Laura Cortesi, Mariangela Gaudio, Grazia Arpino, Giampaolo Bianchini, Francesco Caruso, Saverio Cinieri, Giuseppe Curigliano, Lucia Del Mastro, Sabino De Placido, Alessandra Fabi, Lucio Fortunato, Daniele Generali, Alessandra Gennari, Stefania Gori, Giovanni Grandi, Valentina Guarneri, Marco Klinger, Lorenzo Livi, Caterina Marchiò, Isabella Palumbo, Pietro Panizza, Gabriella Pravettoni, Giancarlo Pruneri, Fabio Puglisi, Anna Sapino, Corrado Tinterri, Daniela Turchetti, Michelino De Laurentiis
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review. Cancer treatment reviews 130 (2024)
Shiting Wu, Anqi Ge, Xianguang Deng, Lifang Liu, Yue Wang
Evolving immunotherapeutic solutions for triple-negative breast carcinoma. Cancer treatment reviews 130 (2024)
Xinlin Liu, Yunlong Song, Panpan Cheng, Bing Liang, Dongming Xing
Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes. Cancer treatment reviews 130 (2024)
Nanxi Zhu, Hao Ni, Shengzhao Guo, Ying-Qiang Shen, Qianming Chen
Bone complications of cancer treatment. Cancer treatment reviews 130 (2024)
Mathilde Gheysen, Kevin Punie, Hans Wildiers, Patrick Neven
Oral SERDs changing the scenery in hormone receptor positive breast cancer, a comprehensive review. Cancer treatment reviews 130 (2024)
Francesco Schettini, Federica Gattazzo, Sabrina Nucera, Elisa Rubio Garcia, Ruben López-Aladid, Lorenzo Morelli, Alessandra Fontana, Paolo Vigneri, Climent Casals-Pascual, Valerio Iebba, Daniele Generali
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications. Cancer treatment reviews 130 (2024)
Chongyu Wang, Pinchao Fan, Qingqing Wang
Evolving therapeutics and ensuing cardiotoxicities in triple-negative breast cancer. Cancer treatment reviews 130 (2024)
Erman Akkus, Çağatay Arslan, Yüksel Ürün
Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectives. Cancer treatment reviews 130 (2024)
Michael Weller, Jordi Remon, Stefan Rieken, Philipp Vollmuth, Myung-Ju Ahn, Giuseppe Minniti, Emilie Le Rhun, Manfred Westphal, Priscilla K Brastianos, Ross A Soo, John P Kirkpatrick, Sarah B Goldberg, Katarina Öhrling, Fiona Hegi-Johnson, Lizza E L Hendriks
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape. Cancer treatment reviews 130 (2024)

volume 129, 2024

Elisa Andrini, Gianluca Ricco, Arianna Zappi, Serena Aloi, Mirela Giordano, Annalisa Altimari, Elisa Gruppioni, Thais Maloberti, Dario de Biase, Davide Campana, Giuseppe Lamberti
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC. Cancer treatment reviews 129 (2024)
Francesco Panzuto, Angela Lamarca, Nicola Fazio
Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumors. Cancer treatment reviews 129 (2024)
J F Tiersma, B Evers, B M Bakker, D J Reijngoud, M de Bruyn, S de Jong, M Jalving
Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act. Cancer treatment reviews 129 (2024)
Martina Bortolot, Francesco Cortiula, Gianpiero Fasola, Dirk De Ruysscher, Jarushka Naidoo, Lizza E L Hendriks
Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials. Cancer treatment reviews 129 (2024)
Patricia Rioja, M Rey-Cardenas, Guillermo De Velasco
Targeting HIF-2α and anemia: A therapeutic breakthrough for clear-cell renal cell carcinoma. Cancer treatment reviews 129 (2024)
Radion Garaz, Cristian Mirvald, Philippe E Spiess, G Daniel Grass, Anita Thomas, Cristian Surcel, Igor Tsaur
Brachytherapy and external beam radiation in the management of primary penile cancer - Game changer for organ preservation? Cancer treatment reviews 129 (2024)
Alexander W Loftus, Mehrdad Zarei, Hanna Kakish, Omid Hajihassani, Jonathan J Hue, Christina Boutros, Hallie J Graor, Faith Nakazzi, Tsegaw Bahlibi, Jordan M Winter, Luke D Rothermel
Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma. Cancer treatment reviews 129 (2024)
Isabel Ripoll-Viladomiu, Adriele Prina-Mello, Dania Movia, Laure Marignol
Extracellular vesicles and the "six Rs" in radiotherapy. Cancer treatment reviews 129 (2024)
Jean-Luc Raoul, Philip D Hansten
Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration. Cancer treatment reviews 129 (2024)
Lauren Jones, David Cunningham, Naureen Starling
HER-2 directed therapies across gastrointestinal tract cancers - A new frontier. Cancer treatment reviews 129 (2024)
Wenqi Zhou, Yeli Yue, Jing Xiong, Wei Li, Xiaohua Zeng
The role of locoregional surgery in de novo stage IV breast cancer: A meta-analysis of randomized controlled trials. Cancer treatment reviews 129 (2024)
Alexander W Loftus, Mehrdad Zarei, Hanna Kakish, Omid Hajihassani, Jonathan J Hue, Christina Boutros, Hallie J Graor, Faith Nakazzi, Tsegaw Bahlibi, Jordan M Winter, Luke D Rothermel
Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma. Cancer treatment reviews 129 (2024)
Alixe Salmon, Alizée Lebeau, Sylvie Streel, Adriane Dheur, Sophie Schoenen, Frédéric Goffin, Elodie Gonne, Frédéric Kridelka, Athanasios Kakkos, Christine Gennigens
Locally advanced and metastatic endometrial cancer: Current and emerging therapies. Cancer treatment reviews 129 (2024)
Linxiaoxi Ma, Benlong Yang, Jiong Wu
Revisiting ovarian function suppression with GnRH agonists for premenopausal women with breast cancer: Who should use and the impact on survival outcomes. Cancer treatment reviews 129 (2024)
Martina Bortolot, Francesco Cortiula, Gianpiero Fasola, Dirk De Ruysscher, Jarushka Naidoo, Lizza E L Hendriks
Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials. Cancer treatment reviews 129 (2024)
Alixe Salmon, Alizée Lebeau, Sylvie Streel, Adriane Dheur, Sophie Schoenen, Frédéric Goffin, Elodie Gonne, Frédéric Kridelka, Athanasios Kakkos, Christine Gennigens
Locally advanced and metastatic endometrial cancer: Current and emerging therapies. Cancer treatment reviews 129 (2024)
Owen A O'Connor, Helen Ma, Jason Yong Sheng Chan, Seok Jin Kim, Sang Eun Yoon, Won Seog Kim
Peripheral T-cell lymphoma: From biology to practice to the future. Cancer treatment reviews 129 (2024)
A Calabrese, C von Arx, A A Tafuti, M Pensabene, M De Laurentiis
Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes. Cancer treatment reviews 129 (2024)
Janet Brown, Daniele Santini, Natalie Charnley, Alessia Ogareva, Alison Chisholm, Robert Jones
Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review. Cancer treatment reviews 129 (2024)
Joanna Socha, Robert Glynne-Jones, Krzysztof Bujko
Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review. Cancer treatment reviews 129 (2024)
Elisa Andrini, Gianluca Ricco, Arianna Zappi, Serena Aloi, Mirela Giordano, Annalisa Altimari, Elisa Gruppioni, Thais Maloberti, Dario de Biase, Davide Campana, Giuseppe Lamberti
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC. Cancer treatment reviews 129 (2024)
Arianna Marinello, Marco Tagliamento, Arianna Pagliaro, Nicole Conci, Eugenia Cella, Damien Vasseur, Jordi Remon, Antonin Levy, Filippo Gustavo Dall'Olio, Benjamin Besse
Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer. Cancer treatment reviews 129 (2024)
Joanna Socha, Robert Glynne-Jones, Krzysztof Bujko
Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review. Cancer treatment reviews 129 (2024)
Donatella Del Bufalo, Giovanna Damia
Overview of BH3 mimetics in ovarian cancer. Cancer treatment reviews 129 (2024)
Arianna Marinello, Marco Tagliamento, Arianna Pagliaro, Nicole Conci, Eugenia Cella, Damien Vasseur, Jordi Remon, Antonin Levy, Filippo Gustavo Dall'Olio, Benjamin Besse
Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer. Cancer treatment reviews 129 (2024)
Owen A O'Connor, Helen Ma, Jason Yong Sheng Chan, Seok Jin Kim, Sang Eun Yoon, Won Seog Kim
Peripheral T-cell lymphoma: From biology to practice to the future. Cancer treatment reviews 129 (2024)
Janet Brown, Daniele Santini, Natalie Charnley, Alessia Ogareva, Alison Chisholm, Robert Jones
Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review. Cancer treatment reviews 129 (2024)
Isabel Ripoll-Viladomiu, Adriele Prina-Mello, Dania Movia, Laure Marignol
Extracellular vesicles and the "six Rs" in radiotherapy. Cancer treatment reviews 129 (2024)
Jean-Luc Raoul, Philip D Hansten
Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration. Cancer treatment reviews 129 (2024)
Benjamin Walbaum, Isabel García-Fructuoso, Olga Martínez-Sáez, Francesco Schettini, César Sánchez, Francisco Acevedo, Nuria Chic, Javier Muñoz-Carrillo, Barbara Adamo, Montserrat Muñoz, Ann H Partridge, Meritxell Bellet, Fara Brasó-Maristany, Aleix Prat, Maria Vidal
Hormone receptor-positive early breast cancer in young women: A comprehensive review. Cancer treatment reviews 129 (2024)
Edoardo De Simoni, Francesco Spagnolo, Sara Gandini, Aurora Gaeta, Giulio Rizzetto, Elisa Molinelli, Oriana Simonetti, Annamaria Offidani, Paola Queirolo
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma. Cancer treatment reviews 129 (2024)
Francesca Papa, Thomas Grinda, Elie Rassy, Rasha Cheickh-Hussin, Joana Ribeiro, Lorenzo Antonuzzo, Barbara Pistilli
Long road towards effective HER3 targeting in breast cancer. Cancer treatment reviews 129 (2024)
Wenqi Zhou, Yeli Yue, Jing Xiong, Wei Li, Xiaohua Zeng
The role of locoregional surgery in de novo stage IV breast cancer: A meta-analysis of randomized controlled trials. Cancer treatment reviews 129 (2024)
Ben O'Leary, Heath Skinner, Jonathan D Schoenfeld, Lisa Licitra, Christophe Le Tourneau, Christina Esdar, Andreas Schroeder, Satu Salmio, Amanda Psyrri
Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck. Cancer treatment reviews 129 (2024)
Yaowen Zhang, Junru Chen, Haoyang Liu, Jindong Dai, Junjie Zhao, Sha Zhu, Xingming Zhang, Jiayu Liang, Xu Hu, Jinge Zhao, Zhenhua Liu, Pengfei Shen, Guangxi Sun, Hao Zeng
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Cancer treatment reviews 129 (2024)